High materiality7/10
BridgeBio price target raised to $106 from $104 at Canaccord
Why it may matterVerify against the original reporting
Buy on upgraded outlook.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord lifts BBIO target to $106; current price reported at $83.7.
- BBIO target up to 106
- BBIO price $83.7
Key facts
- 01
Target: $106
- 02
Posted price: $83.7
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.